Cutaneous lupus erythematosus
MONDO:0005282An autoimmune disorder that manifests as different lupus-specific skin disorders; it can occur with systemic lupus erythematosus, or as a singular disease.
Also known as: lupus erythematosus, cutaneous
81 clinical trials for this condition and its sub-types, 38 tagged with Cutaneous lupus erythematosus itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Cutaneous lupus erythematosus
-
Chronic cutaneous lupus erythematosus 3 trials · 23 incl. sub-types
5 sub-types
- Discoid lupus erythematosus 17 trials
- Chilblain lupus 1 trial · 3 incl. sub-types Sub-types →
- Lupus erythematosus tumidus 3 trials
- Hypertrophic or verrucous lupus erythematosus 0 trials
- Lupus erythematosus panniculitis 0 trials
-
Subacute cutaneous lupus erythematosus 11 trials
-
Rowell syndrome 0 trials
-
Bullous systemic lupus erythematosus 0 trials
Most studied deeper sub-types
-
Lupus skin drug trial halted early – only 8 volunteers joined
Disease control Stopped earlyThis study tested an experimental drug called PF-06823859 for adults with lupus that affects the skin. The goal was to see if the drug could reduce skin inflammation and improve symptoms. The trial was stopped early and only enrolled 8 people instead of the planned 48, so results…
Phase 2 • Sponsor: Pfizer • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Discoid lupus drug trial halted midway
Disease control Stopped earlyThis study tested an experimental drug called daxdilimab in 72 adults with moderate-to-severe discoid lupus erythematosus, a skin condition that causes scarring and hair loss. The goal was to see if the drug could reduce disease activity compared to a placebo. However, the trial …
Phase 2 • Sponsor: Amgen • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Lupus skin drug trial halted early – what we know
Disease control Stopped earlyThis study tested an experimental oral drug called edecesertib (GS-5718) in 20 people with cutaneous lupus erythematosus, a condition where lupus affects the skin. The goal was to see if the drug could reduce skin disease activity and improve symptoms. However, the trial was term…
Phase 2 • Sponsor: Gilead Sciences • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Biopsy tolerance study ends early – what we know
Knowledge-focused Stopped earlyThis study aimed to understand how well patients tolerate biopsies for autoimmune diseases and whether they feel properly informed. It planned to enroll 505 people but was terminated early. The results may help improve patient experience with these common procedures.
Sponsor: University Hospital, Brest • Aim: Knowledge-focused
Last updated Jun 28, 2026 00:00 UTC